Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Texcend Photomask Falls for Third Straight Day Despite Upward Revision to Earnings and Dividend Forecasts
Texcend Photomask <429A> fell for the third consecutive day. After the close of trading on the 27th last week, the company announced an upward revision to its consolidated earnings forecast for the fiscal year ending March 2026, raising its sales forecast from \125.291 billion to \129.2 billion (up 9.5% year-on-year) and net income from \18.878 billion to \23.3 billion (2.3 times the previous year). The company cited robust orders, particularly for advanced products, as well as higher-than-expected derivative valuation gains. The dividend forecast was also increased from \54.39 to \56 (no dividend in the previous year). While the stock price declined in line with the broader market volatility, bargain-hunting buying was observed after the sell-off subsided.
Source: MINKABU PRESS
Related Articles
SONOCOM falls back despite announcement of acquiring precision electroforming business from Maxell◇
Hodogaya Chemical rises against market trend on Hungarian chemical maker acquisition
Daikokuya Holdings Rises on Booking of Gains from Waived Executive Retirement Allowance
ASKUL Ranks 3rd in Rising Sell Predictions Among Individual Investors on Minkabu
ASKUL Plunges on Forecast of \20.5 Billion Operating Loss and \28 Dividend Cut for FY May 2026
FX Summary: Yen firms to upper 159 range against dollar as Vice Finance Minister Mimura warns 'decisive measures may soon be necessary'
Axelspace Holdings Falls for Third Straight Day Despite JAXA Space Strategy Fund Selection
STELLA PHARMA shares fall sharply on TSE margin trading restrictions
ispace Limit Down on Sell Orders After Delay in Next U.S. Mission Launch Plan
HEALIOS Extends Gains on Official Approval of Regenerative Medicine Manufacturing Facility Subsidy◇